MX2018006577A - Metodo para inactivar xenoantigenos en tejidos biologicos. - Google Patents

Metodo para inactivar xenoantigenos en tejidos biologicos.

Info

Publication number
MX2018006577A
MX2018006577A MX2018006577A MX2018006577A MX2018006577A MX 2018006577 A MX2018006577 A MX 2018006577A MX 2018006577 A MX2018006577 A MX 2018006577A MX 2018006577 A MX2018006577 A MX 2018006577A MX 2018006577 A MX2018006577 A MX 2018006577A
Authority
MX
Mexico
Prior art keywords
tissues
biological tissues
treated
xenoantigens
inactivating
Prior art date
Application number
MX2018006577A
Other languages
English (en)
Inventor
NASO Filippo
GANDAGLIA Alessandro
Original Assignee
Biocompatibility Innovation Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocompatibility Innovation Srl filed Critical Biocompatibility Innovation Srl
Publication of MX2018006577A publication Critical patent/MX2018006577A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un método para inactivar xenoantígenos en tejidos biológicos, particularmente en tejidos que se pueden usar para fabricar sustitutos bioprotésicos y/o en sustitutos bioprotésicos que ya están preparados y destinados para uso clínico humano o veterinario. Tal método implica las siguientes etapas: proporcionar una solución basada en compuestos fenólicos, compuestos polifenólicos o derivados de los mismos, para la inactivación de al menos parte de los epítopos xenogénicos de dichos tejidos; incubar las muestra a ser tratadas en las diversas soluciones basadas en fenoles/polifenoles en condiciones controladas; someter los tejidos tratados a una serie de lavados.
MX2018006577A 2015-11-30 2016-11-25 Metodo para inactivar xenoantigenos en tejidos biologicos. MX2018006577A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2015A006019A ITUB20156019A1 (it) 2015-11-30 2015-11-30 Metodo per l'inattivazione di xenoantigeni in tessuti biologici
PCT/EP2016/078898 WO2017093147A1 (en) 2015-11-30 2016-11-25 Method for inactivating xenoantigens in biological tissues

Publications (1)

Publication Number Publication Date
MX2018006577A true MX2018006577A (es) 2018-09-05

Family

ID=55485194

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018006577A MX2018006577A (es) 2015-11-30 2016-11-25 Metodo para inactivar xenoantigenos en tejidos biologicos.

Country Status (19)

Country Link
US (1) US20180353647A1 (es)
EP (1) EP3383446B1 (es)
JP (1) JP7169645B2 (es)
KR (1) KR20180090816A (es)
CN (1) CN108367098B (es)
AU (1) AU2016363536B2 (es)
BR (1) BR112018011021B1 (es)
CA (1) CA3006234A1 (es)
CU (1) CU24631B1 (es)
DK (1) DK3383446T3 (es)
ES (1) ES2881603T3 (es)
IL (1) IL259591B (es)
IT (1) ITUB20156019A1 (es)
MX (1) MX2018006577A (es)
PL (1) PL3383446T3 (es)
RS (1) RS62100B1 (es)
RU (1) RU2754197C2 (es)
WO (1) WO2017093147A1 (es)
ZA (1) ZA201803786B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600115523A1 (it) * 2016-11-16 2018-05-16 Biocompatibility Innovation Srl Metodo per l'inattivazione ed il controllo di avvenuta inattivazione di xenoantigeni in alimenti di origine animale, particolarmente per latte e derivati, e in alimenti di origine vegetale, particolarmente per succedanei di latte a base di soia e/o riso
EP3972659A1 (en) 2019-05-22 2022-03-30 Biocompatibility Innovation Srl Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807463B2 (en) * 2000-01-25 2010-10-05 The Board Of Regents Of The University Of Nebraska Pre-transplant accommodated organs resistant to anti-donor immunity
US20040153145A1 (en) * 2002-11-26 2004-08-05 Clemson University Fixation method for bioprostheses
JP2007529278A (ja) * 2004-03-17 2007-10-25 レビビコア， インコーポレイテッド 機能的α１，３ガラクトシルトランスフェラーゼを欠く動物に由来する組織生成物
BRPI0618485A2 (pt) * 2005-11-10 2012-05-08 Hills Pet Nutrition Inc método, composição e kit para melhorar à saúde da pele e/ou a qualidade da pelagem de um animal, meio para comunicar informação ou instruções, e, uso de uma composição
US20070282422A1 (en) * 2006-05-10 2007-12-06 Cook Incorporated Medical devices and methods for local delivery of elastin-stabilizing compounds
CN101366979B (zh) * 2008-09-03 2012-08-29 陕西瑞盛生物科技有限公司 一种组织补片及其制备方法
FR2947456B1 (fr) * 2009-07-06 2012-03-09 Univ Bordeaux 1 Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain
IL210162A0 (en) * 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
JP2014516695A (ja) * 2011-05-18 2014-07-17 バトリックス・メディカル・インコーポレイテッド 血管安定化用被覆バルーン
RU2495928C2 (ru) * 2012-01-30 2013-10-20 Сергей Юрьевич Лешков Средство для стимуляции синтеза белков теплового шока hsp 70 в клетках человека и животных; косметическое средство для стимуляции репаративных процессов; косметическое средство для снижения побочных эффектов агрессивных косметологических процедур; биологически активная добавка; пищевой продукт; способ снижения побочных эффектов агрессивных косметологических процедур
ITPD20120029A1 (it) * 2012-02-09 2013-08-10 Alessandro Gandaglia Metodo per la rilevazione di uno xenoantigene in tessuti fissati usati come sostituti bioprotesici
US9795573B2 (en) * 2013-09-24 2017-10-24 Clemson University Multi-step connective tissue stabilization method and stabilized tissue formed thereby

Also Published As

Publication number Publication date
CN108367098B (zh) 2021-06-11
WO2017093147A1 (en) 2017-06-08
IL259591B (en) 2022-04-01
US20180353647A1 (en) 2018-12-13
JP2019503821A (ja) 2019-02-14
AU2016363536B2 (en) 2021-04-01
RS62100B1 (sr) 2021-08-31
CU24631B1 (es) 2022-12-12
CU20180048A7 (es) 2018-11-06
PL3383446T3 (pl) 2021-11-02
CA3006234A1 (en) 2017-06-08
BR112018011021B1 (pt) 2021-12-07
RU2754197C2 (ru) 2021-08-30
RU2018123621A (ru) 2020-01-09
EP3383446B1 (en) 2021-04-28
CN108367098A (zh) 2018-08-03
DK3383446T3 (da) 2021-07-26
ITUB20156019A1 (it) 2017-05-30
JP7169645B2 (ja) 2022-11-11
ZA201803786B (en) 2019-02-27
EP3383446A1 (en) 2018-10-10
RU2018123621A3 (es) 2020-04-10
IL259591A (en) 2018-07-31
AU2016363536A1 (en) 2018-06-28
BR112018011021A2 (pt) 2018-11-21
ES2881603T3 (es) 2021-11-30
KR20180090816A (ko) 2018-08-13

Similar Documents

Publication Publication Date Title
MX2018011114A (es) Métodos y composiciones relacionadas con crispr/cas para el tratamiento de beta hemoglobinopatías.
WO2015148863A3 (en) Crispr/cas-related methods and compositions for treating sickle cell disease
AU2019268188A1 (en) Sterile chromatography resin and use thereof in manufacturing processes
AR107242A1 (es) Preparación térmica de esporas bacterianas
EP3564356A4 (en) SOLUTION FOR CRYOPRESERVATION, CRYOGENIZATION PRODUCT, AND METHOD FOR CRYOPRESERVATION OF ANIMAL CELLS OR ANIMAL TISSUES
MX2019009753A (es) Composicion y metodos para prevenir lesion por radiacion y promover la regeneracion de tejidos.
EP3268319A4 (en) Process and facility for the treatment of livestock waste
MX368725B (es) Sistema cerrado integrado de extraccion de linea intravenosa.
MX2018011984A (es) Extractos de uva y métodos relacionados con los mismos.
HK1244211A1 (zh) 治療、預防或降低皮膚感染風險的方法
MX2018006577A (es) Metodo para inactivar xenoantigenos en tejidos biologicos.
HK1258999A1 (zh) 用於治療肝臟和維持肝臟健康的組合物、方法和藥物組合物
BR112017020013A2 (pt) método para preparação de um substituto da pele, substituto da pele, substituto dérmico, enxerto, enxerto para uso, e kit para implementação do método
TW201613569A (en) Composition consisting of kukoamine A and/or kukoamine B and method of using thereof
RS64368B1 (sr) Postrojenje i postupak za tretman otpada, posebno otpada iz laboratorija za medicinsku analizu
MX2017000118A (es) Biocontrol de enfermedades asociadas a la semilla en plantulas.
SG11201901617PA (en) Azole compound ophthalmic preparation
CR20170543A (es) Métodos de tratamiento de plantas de cultivo.
MX2018001985A (es) Metodo para reducir patogenos en y/o sobre un sujeto.
GB2549031A (en) Methods and drug therapies for patency of occluded blood vessels following angioplasty
BR112017011490A2 (pt) método para tratar condição inflamatória ou isquêmica em um órgão ou tecido de um paciente
PL3481194T3 (pl) Wodne kompozycje do zaprawiania nasion, zaprawione nimi nasiona i sposoby zaprawiania nasion
EP3481372A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEART DISEASES
MX2018005566A (es) Dispositivo y metodo para el tratamiento de un implante oseo artificial con sangre.
EP3386503A4 (en) METHOD AND FORMULATIONS FOR THE TREATMENT OF VASCULAR DISEASES